0001683168-25-005718.txt : 20250807 0001683168-25-005718.hdr.sgml : 20250807 20250806174101 ACCESSION NUMBER: 0001683168-25-005718 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250806 EFFECTIVENESS DATE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Coeptis Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001759186 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] ORGANIZATION NAME: 09 Crypto Assets EIN: 981465952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553921 FILM NUMBER: 251190839 BUSINESS ADDRESS: STREET 1: 105 BRADFORD ROAD, SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 BUSINESS PHONE: 724-934-6467 MAIL ADDRESS: STREET 1: 105 BRADFORD ROAD, SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 FORMER COMPANY: FORMER CONFORMED NAME: Bull Horn Holdings Corp. DATE OF NAME CHANGE: 20181115 D 1 primary_doc.xml X0708 D LIVE 0001759186 Coeptis Therapeutics Holdings, Inc. 105 BRADFORD ROAD SUITE 420 WEXFORD PA PENNSYLVANIA 15090 724-934-6467 DELAWARE None Bull Horn Holdings Corp. Corporation true 2022 David Mehalick 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Daniel Yerace 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Brian Cogley 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Christopher Calise 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Christopher Cochran 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Tara Maria DeSilva 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Philippe Deschamps 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Gene Salkind 105 BRADFORD ROAD SUITE 420 Wexford PA PENNSYLVANIA 15090 Director Pharmaceuticals Decline to Disclose 06b false 2025-07-24 false true false 100000 5000000 4000000 1000000 false 9 0 0 0 false Coeptis Therapeutics Holdings, Inc. /s/ David Mehalick David Mehalick Chairman, Chief Executive Officer and President 2025-08-06